Randomized clinical trials in esophageal carcinoma Journal Article
| Authors: | Barnett, S. A.; Rizk, N. P. |
| Article Title: | Randomized clinical trials in esophageal carcinoma |
| Abstract: | The treatment of esophageal cancer with curative intent remains highly controversial, with advocates of surgery alone, chemoradiotherapy alone, surgery with adjuvant therapy (including neoadjuvant and postoperative), and trimodality therapy each contributing prospective randomized controlled trials (PRCTs) to the body of scientific publications between 2000 and 2008. Any improvements in survival have been small in absolute percentage terms, and as such PRCTs published over the last decade have met the same primary obstacle encountered by the studies from the two prior decades, namely lack of power to detect small differences in outcome. Variations in staging methods, surgical technique, radiotherapy technique, and chemotherapy regime have in turn been the subject of PRCTs over the last nine years. In many cases primary end points have not been survival but rather rates of complication or response. As well as giving an overview of PRCTs, this article collates the level Ia evidence published to date. © 2010 Elsevier Inc. All rights reserved. |
| Keywords: | cancer chemotherapy; cancer survival; controlled study; cancer surgery; surgical technique; clinical trial; drug tolerability; neutropenia; review; squamous cell carcinoma; cisplatin; doxorubicin; fluorouracil; advanced cancer; diarrhea; drug dose comparison; drug withdrawal; multimodality cancer therapy; capecitabine; cancer adjuvant therapy; methotrexate; cancer staging; cancer palliative therapy; quality of life; controlled clinical trial; multiple cycle treatment; nephrotoxicity; etoposide; neuropathy; randomized controlled trial; stomatitis; thoracotomy; thrombocytopenia; randomized controlled trials as topic; continuous infusion; surgical approach; docetaxel; irinotecan; drug fatality; thromboembolism; folinic acid; erythema; brachytherapy; esophagus resection; cancer relapse; epirubicin; external beam radiotherapy; mitomycin; anthracycline; oxaliplatin; esophageal adenocarcinoma; lethargy; stomach adenocarcinoma; alopecia; literature review; esophagus carcinoma; esophageal neoplasms; esophageal cancer; level ia evidence; prospective randomized controlled trials |
| Journal Title: | Surgical Oncology Clinics of North America |
| Volume: | 19 |
| Issue: | 1 |
| ISSN: | 1055-3207 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2010-01-01 |
| Start Page: | 59 |
| End Page: | 80 |
| Language: | English |
| DOI: | 10.1016/j.soc.2009.09.007 |
| PUBMED: | 19914560 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "CODEN: SOCAF" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work